Nisoxetine
Structural formula | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1: 1 mixture (racemate) of the ( R ) form (left) and the ( S ) form (right) | ||||||||||||||||
General | ||||||||||||||||
Non-proprietary name | Nisoxetine | |||||||||||||||
other names | ||||||||||||||||
Molecular formula | C 17 H 21 NO 2 | |||||||||||||||
Brief description |
colorless solid (hydrochloride) |
|||||||||||||||
External identifiers / databases | ||||||||||||||||
|
||||||||||||||||
Drug information | ||||||||||||||||
Drug class | ||||||||||||||||
Mechanism of action | ||||||||||||||||
properties | ||||||||||||||||
Molar mass | 271.35 g · mol -1 | |||||||||||||||
Physical state |
firmly |
|||||||||||||||
pK s value |
10.162 |
|||||||||||||||
solubility |
|
|||||||||||||||
safety instructions | ||||||||||||||||
|
||||||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Nisoxetine ( LY-94939 ) is a selective norepinephrine reuptake inhibitor (NARI).
It was originally developed as an antidepressant but did not get beyond the development stage. However, it is considered the “standard NARI” in scientific research and is often used as such. It is used as a racemate .
Individual evidence
- ↑ a b c d data sheet Nisoxetine hydrochloride from Sigma-Aldrich , accessed on April 16, 2011 ( PDF ).
- ↑ Nisoxetine, Compound ID CHEMBL295467 in the ChEMBL database.
- ↑ S. Kelwala, M. Stanley, S. Gershon: History of antidepressants: successes and failures. In: Journal of Clinical Psychiatry. 44 (5 Pt 2), May 1983, pp. 40-48. PMID 6222036 .
- ^ D. Graham, SZ Langer: Advances in sodium-ion coupled biogenic amine transporters. In: Life Sciences . 51 (9), 1992, pp. 631-645. PMID 1501510 .